03 Oct
|
Sarepta Therapeutics
|
Field
03 Oct
Sarepta Therapeutics
Field
The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne.
The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne.
At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. For a full list of our comprehensive benefits, see our website: The Medical Science Liaison (MSL) plays a pivotal role in establishing and fostering peer-to-peer relationships with healthcare professionals (HCPs)
involved in the management of neuromuscular diseases in line with Sarepta's marketed and investigational product pipeline.
The candidate will have expertise in the field of Neurology / Pediatrics and be a scientific expert regarding Sarepta's portfolio of products. The MSL will serve as a resource for scientific information for key customers, including but not limited to national and regional opinion leaders, investigators, advisors, and physician networks. The successful candidate will be highly driven individual who combines scientific knowledge with customer service, business acumen, and compassion for the patients we serve.
This position requires extensive travel and requires the candidate to be located in IL/MI/IN/WI and covering a territory of the followingstates: Develops and implements rolling and goal-oriented KOL field engagement strategy that demonstrates ownership of the execution of the medical strategy, projects and initiatives with their region. Demonstrates robust knowledge of disease-state and product/platform data through communication of complex clinical data and product information in a clear, compliant, and non-promotional manner Collects high quality, actionable feedback and reports #
📌 Medical Science Liaison: Field Based
🏢 Sarepta Therapeutics
📍 Field